CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Medical Coverage Policy | Intracellular Micronutrient Analysis

Defines coverage stance for intracellular micronutrient panel testing (laboratory-developed tests measuring intracellular vitamins/minerals) for Blue Cross Blue Shield - Rhode Island members across Commercial and Medicare lines.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyMedical Coverage Policy | Intracellular Micronutrient Analysis

Policy CodePolicy N/A

Change TypeNo material change

Effective DateJun 1, 2017

Next Review Date

Key ActionClaims for intracellular micronutrient panels should be filed with an unlisted CPT code and should not be reported using specific CPT codes for individual panel elements.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes reported.

Not covered/Not medically necessaryCoverage summary

2Reference labs

0RCTs identified

Coverage Summary

Intracellular micronutrient analysis measures intracellular levels of vitamins, minerals, antioxidants, amino acids, and metabolites using samples such as lymphocytes (SpectraCell) or buccal epithelial cells (IntraCellular Diagnostics). These tests are offered by commercial reference laboratories and are often marketed as laboratory-developed tests (LDTs) performed under CLIA high-complexity standards.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

BlueCHiP for Medicare states the testing is not covered, and the policy considers it not medically necessary for Commercial members because the evidence is insufficient to determine effects on health outcomes. Quick facts: 2 reference laboratories identified and 0 randomized controlled trials supporting clinical impact.

Policy header

Effective date06/01/2017

Last review11/19/2019

StatusCURRENT

SubjectIntracellular Micronutrient Analysis

Scope summaryDefines coverage stance for intracellular micronutrient panel testing (laboratory-developed tests measuring intracellular vitamins/minerals) for Blue Cross Blue Shield - Rhode Island members across Commercial and Medicare lines.

Medical-Necessity Determinations

BlueCHiP for Medicare Coverage Determination

Intracellular micronutrient panel testing is:

Not covered because the evidence is insufficient to determine the effects of the technology on health outcomes

Commercial Coverage Determination

Intracellular micronutrient panel testing is:

Considered not medically necessary as the evidence is insufficient to determine the effects of the technology on health outcomes

Not Covered / Experimental

The policy rationale for noncoverage is that there are no studies demonstrating analytic validity, clinical validity, or clinical utility of intracellular testing compared with standard serum testing, and no randomized controlled trials or comparative studies showing improved health outcomes.

Coding

Unlisted code reporting for panelCPT

Unlisted CPT code

There is no specific CPT code for this panel; claims should be filed with an unlisted code and should not be reported with the specific CPT codes for each of the elements of the panel.

Provider Actions & Billing Impact

Billing Rule

Use unlisted CPT code

Claims for intracellular micronutrient panels should be filed with an unlisted CPT code and should not be reported using specific CPT codes for individual panel elements.

Unlisted CPT code

Denial Risk

Not covered / not medically necessary

Intracellular micronutrient panel testing is not covered for Medicare members and is considered not medically necessary for commercial members; claims are at risk for denial.

Background & Evidence Summary

Intracellular micronutrient analysis tests intracellular levels of essential vitamins and minerals and may be proposed for screening or evaluation of nonspecific symptoms. Sample types include lymphocytes from blood (SpectraCell) and buccal epithelial cells from swabs (IntraCellular Diagnostics).

Classic nutritional deficiency diseases are uncommon in the United States; serum tests using standardized values are the standard method to confirm suspected micronutrient deficiencies. There is no specific CPT code for the intracellular panel and claims should be filed with an unlisted code rather than individual element CPT codes.

Evidence summary

Randomized controlled trials identifiedNone

Comparative studies evaluating health impactNone identified

Observational studiesLimited; correlations between serum and intracellular levels are limited

Intracellular micronutrient analysis: Laboratory tests that measure intracellular levels of micronutrients (vitamins, minerals, antioxidants, amino acids, metabolites), often marketed as LDTs by reference labs such as SpectraCell and IntraCellular Diagnostics.

Laboratory-developed test (LDT): A test developed and validated in-house by a clinical laboratory and marketed as a laboratory service; regulated under CLIA for high-complexity testing.

Medicare Determinations

Intracellular micronutrient panel testing — BlueCHiP for Medicare: Not covered (NCD).

Revision History

2017-06-01effective_date

Policy effective date

2019-11-19last_reviewLatest

Last review